CA2342855A1 - Novel pyranoses - Google Patents

Novel pyranoses Download PDF

Info

Publication number
CA2342855A1
CA2342855A1 CA002342855A CA2342855A CA2342855A1 CA 2342855 A1 CA2342855 A1 CA 2342855A1 CA 002342855 A CA002342855 A CA 002342855A CA 2342855 A CA2342855 A CA 2342855A CA 2342855 A1 CA2342855 A1 CA 2342855A1
Authority
CA
Canada
Prior art keywords
dideoxy
benzyl
ylcarbonyl
piperazin
glucopyranose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002342855A
Other languages
English (en)
French (fr)
Inventor
Thomas Martin
Thomas Bar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2342855A1 publication Critical patent/CA2342855A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/12—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by acids having the group -X-C(=X)-X-, or halides thereof, in which each X means nitrogen, oxygen, sulfur, selenium or tellurium, e.g. carbonic acid, carbamic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA002342855A 1998-09-04 1999-08-27 Novel pyranoses Abandoned CA2342855A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP98116777 1998-09-04
EP98116777.8 1998-09-04
DE19937718.9 1999-08-10
DE19937718 1999-08-10
PCT/EP1999/006325 WO2000014097A2 (de) 1998-09-04 1999-08-27 Neue pyranosen

Publications (1)

Publication Number Publication Date
CA2342855A1 true CA2342855A1 (en) 2000-03-16

Family

ID=26054555

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002342855A Abandoned CA2342855A1 (en) 1998-09-04 1999-08-27 Novel pyranoses

Country Status (6)

Country Link
EP (1) EP1115731A2 (de)
JP (1) JP2003524598A (de)
AU (1) AU5625499A (de)
CA (1) CA2342855A1 (de)
IL (1) IL141654A0 (de)
WO (1) WO2000014097A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001036386A1 (fr) * 1999-11-17 2001-05-25 Sumitomo Pharmaceuticals Co., Ltd. Traitement du diabete contenant un derive de dipiperazine
CA2392121A1 (en) 1999-12-20 2001-06-28 Byk Gulden Lomberg Chemische Fabrik Gmbh Tryptase inhibitors
US6815557B2 (en) 1999-12-20 2004-11-09 Altana Pharma Ag Tryptase inhibitors
ATE273302T1 (de) 2001-01-31 2004-08-15 Altana Pharma Ag Diazocinderivate und deren verwendung als tryptase inhibitoren
WO2002066420A2 (en) 2001-02-21 2002-08-29 Altana Pharma Ag Tryptase inhibitors
WO2002066430A1 (en) 2001-02-21 2002-08-29 Altana Pharma Ag Tryptase inhibitors
CA2450659A1 (en) 2001-06-19 2002-12-27 Altana Pharma Ag Tryptase inhibitors
WO2003075853A2 (en) 2002-03-08 2003-09-18 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
EP2431744A1 (de) * 2010-09-20 2012-03-21 Bioftalmik, S.L. Diagnostisches in vitro Verfahren zum Nachweis von Allergien des Auges bei Kindern
US20210087143A1 (en) * 2017-03-29 2021-03-25 Minerva Biotechnologies Corporation Agents for differentiating stem cells and treating cancer
CA3220039A1 (en) 2021-06-14 2022-12-22 Jr. David St. Jean Urea derivatives which can be used to treat cancer

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993017032A1 (en) * 1992-02-24 1993-09-02 The Trustees Of The University Of Pennsylvania Techniques and intermediates for preparing non-peptide peptidomimetics
ES2150941T3 (es) * 1992-04-03 2000-12-16 Upjohn Co Aminas biciclicas-heterociclicas eficaces farmaceuticamente.
DE4338015A1 (de) * 1993-11-08 1995-05-11 Asta Medica Ag Verwendung von D-glucopyranuronsäuren und deren Derivaten zum Einbau in pharmakologisch wirksame Peptide und deren Salze
HUT77345A (hu) * 1994-04-29 1998-03-30 Texas Biotechnology Corporation E-szelektin, P-szelektin vagy L-szelektin szialil-Lewis x-hez vagy szialil-Lewis a-hoz kapcsolódását gátló mannopiranoziloxi-bifenil származékok és ezeket tartalmazó gyógyszerkészítmények
EP0763016B1 (de) * 1994-06-01 2000-01-26 Axys Pharmaceuticals, Inc. Zusammensetzungen und verfahren zur behandlung von durch mast-zellen verursachten krankheiten
JPH10506390A (ja) * 1994-09-23 1998-06-23 アリス ファーマシューティカル コーポレイション マスト細胞炎症症状を処置するための組成物及び方法
EP0840606B1 (de) * 1995-06-29 2000-06-07 Texas Biotechnology Corporation Di- und trivalente kleine moleküle als selektininhibitoren
CZ29799A3 (cs) * 1996-07-30 1999-06-16 Arris Pharmaceutical Corporation Disubstituovaná cyklická sloučenina, způsob její výroby, farmaceutický přípravek a způsob léčení onemocnění živočicha
DE19637123A1 (de) * 1996-09-12 1998-03-19 Boehringer Ingelheim Kg Neue Pyranosidderivate

Also Published As

Publication number Publication date
JP2003524598A (ja) 2003-08-19
IL141654A0 (en) 2002-03-10
AU5625499A (en) 2000-03-27
WO2000014097A2 (de) 2000-03-16
WO2000014097A3 (de) 2000-07-20
EP1115731A2 (de) 2001-07-18

Similar Documents

Publication Publication Date Title
CA2206532C (en) Novel amidinonaphthyl derivative or salt thereof
AU2007241343B2 (en) Purine derivatives for use as adenosin A2A receptor agonists
CA3010890C (en) Quinolin-2-one derivatives
CA2680366C (en) Inhibitors of carnitine palmitoyltransferase and treating cancer
US6489327B1 (en) Tryptase inhibitors
CA2342855A1 (en) Novel pyranoses
AU2006331850A1 (en) Substituted aniline derivatives useful as histamine H3 antagonists
EP1996545A1 (de) Lösliche epoxidhydrolasehemmer und verfahren zu ihrer verwendung
AU778965B2 (en) Tryptase inhibitors
JP2002502845A (ja) トリプターゼ阻害物質
CN106928252B (zh) 一种抑制rock的化合物及其制备方法与应用
US7015325B2 (en) Tryptase inhibitors
TW202045506A (zh) 吡唑化合物
ES2230155T3 (es) Derivados de diazocin-diona y su uso como inhibidores de triptasa.
EP1368317B1 (de) Tryptaseinhibitoren
EP1358182B1 (de) Diazocinderivate und deren verwendung als tryptase inhibitoren
CA3225756A1 (en) Galactoside derivative as galectin-3 inhibitor
AU2002253035A1 (en) Tryptase inhibitors

Legal Events

Date Code Title Description
FZDE Discontinued